Webinar Duration: 90 minutes

RECORDED: Access recorded version only for one participant; unlimited viewing for 6 months (Access information will be emailed 24 hours after the completion of payment)

SPEAKER: Robert J. Russell

OVERVIEW:
The course also covers recent updates on EU GCP associated with the Directive, the highlights of the new EU Pharmacovigilance Directive, as it relates to studies and helpful tips into working with the European regulators.

Additionally, changes to the Clinical Trial Directive are being contemplated and the Course Director will provide insight into those areas, which may receive modification.

Learning Objectives: Attendees will leave the Course clearly understanding the requirements under the current Directive. In addition, this Course has been updated to provide participants with competitive insight into:
– How to efficiently initiate trials
– How to link the strategy of Country Selection to an ultimate EU Licensing Plan
– Efficiently implementing studies via project teams and CROs at the National and multi-state level
– How to stay compliant…..What can make the difference in your data passing Regulatory scrutiny.
– Related area-GCP and PV-reporting updates
– EUCTD vs. FDA Regulations

Areas Covered in the Session:
– Overview of the EU and the EU Regulatory Structure
– Marketing Authorization Options in the EU
– Overview of the European Union Clinical Trial Directive
– 2007 Pediatric Legislation
– Processes and Timelines
– The Ethics Committee
– Phases of a Clinical Trial
– Trial Protocol and Project Management
– Investigational Medicinal Product Dossier
– Standard Operating Procedures
– Clinical Trial Authorization Application
– Good Clinical Practice
– Good Manufacturing Practice
– Pharmacovigilance
– Handling the end of Clinical Trial
– Clinical Trial Databases
– European Union vs. The United States
– Regulatory Process in the EU
– Recent updates to the Directive

Who Will Benefit:
– Clinical Operations Staff
– Project Team Members
– Quality Assurance, Monitors, CRAs
– Regulatory Affairs
– Investigators & Site Study Staff
– Clinical Trial Supply
– CROs, Consultants, Insurers

SPEAKER PROFILE:
Robert J. Russell For the past 9 years, Bob has been President of RJR Consulting, Inc. The company assists the pharmaceutical, medical device and biotech industries in understanding and complying with International Regulations affecting compliance, new product development, manufacturing and quality assurance. RJR has offices in Columbus, OH, Washington, DC, Brussels, Belgium with exclusive affiliates across Asia and Latin America. Bob has 28 years of past industry experience as a CMC specialist, R&D Director and Global Director of Regulatory Affairs for Merion Merrill Dow pharmaceuticals and Cordis-Dow medical devices. He has a BS / MS degree in Chemistry.